Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00401141 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Abnormalities of B Lymphocytes During Systemic Lupus

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Apr 2008
    • Study completion date: May 2009
    v5
  2. Publications: details revised at 1 of 1 entryv4
  3. Study Status, Sponsor/Collaborators, Referencesv3
  4. Trial status: Recruiting to Completed
    • Site details revised
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Previous experimental data strongly suggest that B lymphocytes have intrinsic abnormalities during lupus in mice spontaneously affected by the disease. This study tries to define these abnormalities by looking at the gene expression profile of purified B lymphocytes from patients with non active systemic lupus , compared with the gene expression profile of purified B lymphocytes from healthy donnors.
Trial Details
NCT Number NCT00401141
Lead Sponsor University Hospital, Strasbourg, France
Conditions
(from sponsor)		 Systemic Lupus Erythematosus
Related terms Lupus Erythematosus, Systemic
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov